RANAR Team
Mike Gallatin
David McElligott
David McElligott
Co-founder & Chairman
David McElligott
David McElligott
David McElligott
Co-founder & CSO
Gabriele Varani
David McElligott
Gabriele Varani
Co-founder & Director
Steve Bender
Nikos Pagratis
Gabriele Varani
SVP, Chemistry
Nikos Pagratis
Nikos Pagratis
Nikos Pagratis
SVP, Biology
Sylvia Tara
Nikos Pagratis
Nikos Pagratis
Head of Corporate Strategy
RANAR Advisors
Mike Carleton, Ph.D.
Mike Carleton, Ph.D.
Mike Carleton, Ph.D.
- Target Selection Advisor
- Aprea Therapeutics
- The Mark Foundation for Cancer Research
- Inipharm
- Mavu
- Bristol Myers Squibb
Heather Hsu, Ph.D.
Mike Carleton, Ph.D.
Mike Carleton, Ph.D.
- Target Selection Advisor
- Inipharm
- Gilead
- Calistoga
Danny Incarnato, Ph.D.
Danny Incarnato, Ph.D.
Danny Incarnato, Ph.D.
- RNA Structure Advisor
- University of Groningen
- Expert on RNA SHAPE analysis, and DRACO (Deconvolution of RNA Alternative COnformations)
Bruce Roth, Ph.D.
Danny Incarnato, Ph.D.
Danny Incarnato, Ph.D.
- Chemistry Advisor
- Roth Pharma Consulting, LLC
- Former Sr. VP Small Molecule Drug Discovery, Genentech
- Awarded Perkin Medal